Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-19 Sale | 2024-11-21 6:52 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 38,689 | $16.78 | $649,030 | 400,600 (Direct) | View |
| 2024-11-14 Sale | 2024-11-18 7:32 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 82,368 | $17.46 | $1,438,038 | 536,257 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-19 Exercise | 2024-11-21 6:52 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 38,689 | $1.41 | 400,600 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-21 6:52 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 38,689 | $0 | 400,600 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:32 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 82,368 | $1.41 | 536,257 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:32 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 82,368 | $0 | 536,257 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 9:30 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 249,598 | $0 | 358,860 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:03 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Operating Officer | 3,496,000 | $0 | 3,496,000 (Direct) | View |
| 2023-11-13 Option Award | 2023-11-15 4:42 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Operations Officer | 7,270 | $0 | 7,270 (Direct) | View |